Go Ad-Free
My Alerts
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & Drugs

| BSE 1416.75 -9.65 (-0.68%) | |

BSE Live

Feb 11, 10:20
1416.75 -9.65 (-0.68%)
Volume
AVERAGE VOLUME
5-Day
87,217
10-Day
51,932
30-Day
46,703
808

  • Prev. Close

    1426.40

  • Open Price

    1406.60

  • Bid Price (Qty.)

    1414.45 (24)

  • Offer Price (Qty.)

    1416.60 (3)

NSE Live

Feb 11, 10:19
1415.00 -11.20 (-0.79%)
Volume
AVERAGE VOLUME
5-Day
129,070
10-Day
175,676
30-Day
234,308
29,809

  • Prev. Close

    1426.20

  • Open Price

    1424.10

  • Bid Price (Qty.)

    1415.00 (19)

  • Offer Price (Qty.)

    1416.30 (8)

Financials

Cash Flow of Ipca Laboratories (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 999.77 822.16 750.49 1,088.36 1,379.96  
Net CashFlow From Operating Activities 1,374.07 830.51 762.29 840.14 1,096.06  
Net Cash Used In Investing Activities -738.81 -1,355.18 -709.61 -823.89 -559.56  
Net Cash Used From Financing Activities -428.44 -464.88 506.38 426.10 -307.38  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 206.82 -989.55 559.06 442.35 229.12  
Cash And Cash Equivalents Begin of Year 515.28 1,504.83 945.77 501.19 272.07  
Cash And Cash Equivalents End Of Year 722.10 515.28 1,504.83 943.54 501.19  
Source : Dion Global Solutions Limited

Results of Ipca Labs

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026